Clara Agutu is a medical doctor with a Masters in public health. She has a keen interest in infectious diseases particularly HIV, TB, Malaria and sexually transmitted infections (STIs) and has worked as a research medical officer at KEMRI. She worked as the lead clinician and study co-ordinator for a multi-centre HIV clinical trial, REALITY (Reduction of Early Mortality in HIV-infected Adults and Children starting Anti-retroviral Therapy), looking to investigate interventions aimed at reducing early mortality during the first three months of starting anti-retroviral therapy, when mortality is the highest in the severely immune-suppressed. She is currently a WHO/TDR clinical research and development fellow at GlaxoSmithKline Biologicals, Belgium working on the malaria vaccine, RTS, S, particularly on phase 2 and 3 trials aimed at improving the vaccines efficacy and subsequent implementation in sub-Saharan Africa. Her SANTHE PhD studentship is in the field of acute HIV screening, for early HIV infection detection and reduction of HIV transmission as she continues the global fight towards the elimination of HIV.